62 / 64
S60
AFRICA
CVJAFRICA • Volume 26, No 2, H3Africa Supplement, March/April 2015
28. Bradley EH, Curry LA, Ramanadhan S, Rowe L, Nembhard IM,
Krumholz HM. Research in action: using positive deviance to improve
quality of health care.
Implement Sci
2009;
4
: 25.
29. Emerging Risk Factors C, Kaptoge S, Di Angelantonio E, Pennells L,
Wood AM, White IR, Gao P,
et al
. C-reactive protein, fibrinogen, and
cardiovascular disease prediction.
N Engl J Med
2012;
367
: 1310–1320.
30. Brotman DJ, Walker E, Lauer MS, O’Brien RG. In search of fewer inde-
pendent risk factors.
Arch Intern Med
2005;
165
: 138–145.
31. Voight BF, Peloso GM, Orho-Melander M, Frikke-Schmidt R, Barbalic
M, Jensen MK,
et al
. Plasma HDL cholesterol and risk of myocardial
infarction: a mendelian randomisation study.
Lancet
2012;
380
: 572–580.
32. Investigators A-H, Boden WE, Probstfield JL, Anderson T, Chaitman
BR, Desvignes-Nickens P, Koprowicz K,
et al
. Niacin in patients with
low HDL cholesterol levels receiving intensive statin therapy.
N Engl J
Med
2011;
365
: 2255–2267.
33. Chatsuriyawong S, Gozal D, Kheirandish-Gozal L, Bhattacharjee R,
Khalyfa AA, Wang Y,
et al
. Genetic variance in nitric oxide synthase
and endothelin genes among children with and without endothelial
dysfunction.
J Translational Med
2013;
11
: 227.
JOINT CONGRESS BETWEEN THE PAN-AFRICAN SOCIETY OF CARDIOLOGY
AND
TUNISIAN SOCIETY OF CARDIOLOGY AND CARDIOVASCULAR SURGERY
FOR MORE INFORMATION CONTACT:
Faiza Pearce (Londocor Event Management, South Africa)
Tel: +27 21 393 5950 / E-mail:
faiza@londocor.co.za www.pascar-stcccv2015.org3 – 7 October 2015
Médina Yasmine Hammamet
Tunisia
SAVE THE DATE